AIM: To evaluate the therapeutic effect of aflibercept in patients with suboptimal response to ranibizumab therapy in the early period. METHOD: Thirty-eight patients with wet type age related macular degeneration(W-AMD) were involved in this study. Eighteen patients with suboptimal response were shifted to 3 doses monthly intravitreal aflibercept therapy (IVA) and left 20 patients with suboptimal response went on 3 more monthly intravitreal ranibizumab (IVR). All changes were evaluated with fluorescein anigography (FA) and optical coherence tomography (OCT). RESULTS: Preoperative mean visual acuity (VA) and central macular thickness (CMT) of patients were 0.84±0.47 logMAR and 360±84 ?m, respectively. One month after last IVR and IVA treatme...
A retrospective chart review of patients with persistent subretinal and/or intraretinal fluid, despi...
To investigate visual and anatomical outcomes in eyes with exudative age-related macular degeneratio...
Purpose. - To compare the changes in subfoveal choroidal thickness after intravitreal ranibizumab or...
ABSTRACT Purpose: The present study compared the efficacy of aflibercept for neovascular age-relate...
PURPOSE: To investigate the time course of pigment epithelium detachment (PED) height and its change...
Purpose: To evaluate individualized intravitreal aflibercept regimens for treatment of neovascular a...
Background Age-related macular degeneration (AMD) is a degenerative process that leads to severe vis...
International audiencePURPOSE:To assess the effect of intravitreal ranibizumab and aflibercept on re...
Purpose: The aim of this study was to evaluate the effect of switching from aflibercept to ranibizum...
Purpose: This study was designed to assess the functional and anatomic outcomes of intravitreal afli...
Toshiaki Hirakata,1,2,* Kaoru Fujinami,1,3,4,* Ken Watanabe,5 Mariko Sasaki,1,3,6 Toru Noda,1,5 Kuni...
PubMedID: 30793798Background: The purpose of this study was to investigate changes in best-corrected...
Purpose To evaluate the effects of aflibercept administered according to a pro re nata (PRN) or Fixe...
Purpose. To assess mean changes in visual acuity, central retinal thickness and macular volume as we...
PURPOSE: To compare the effects of converting to aflibercept therapy with continuing ranibizumab the...
A retrospective chart review of patients with persistent subretinal and/or intraretinal fluid, despi...
To investigate visual and anatomical outcomes in eyes with exudative age-related macular degeneratio...
Purpose. - To compare the changes in subfoveal choroidal thickness after intravitreal ranibizumab or...
ABSTRACT Purpose: The present study compared the efficacy of aflibercept for neovascular age-relate...
PURPOSE: To investigate the time course of pigment epithelium detachment (PED) height and its change...
Purpose: To evaluate individualized intravitreal aflibercept regimens for treatment of neovascular a...
Background Age-related macular degeneration (AMD) is a degenerative process that leads to severe vis...
International audiencePURPOSE:To assess the effect of intravitreal ranibizumab and aflibercept on re...
Purpose: The aim of this study was to evaluate the effect of switching from aflibercept to ranibizum...
Purpose: This study was designed to assess the functional and anatomic outcomes of intravitreal afli...
Toshiaki Hirakata,1,2,* Kaoru Fujinami,1,3,4,* Ken Watanabe,5 Mariko Sasaki,1,3,6 Toru Noda,1,5 Kuni...
PubMedID: 30793798Background: The purpose of this study was to investigate changes in best-corrected...
Purpose To evaluate the effects of aflibercept administered according to a pro re nata (PRN) or Fixe...
Purpose. To assess mean changes in visual acuity, central retinal thickness and macular volume as we...
PURPOSE: To compare the effects of converting to aflibercept therapy with continuing ranibizumab the...
A retrospective chart review of patients with persistent subretinal and/or intraretinal fluid, despi...
To investigate visual and anatomical outcomes in eyes with exudative age-related macular degeneratio...
Purpose. - To compare the changes in subfoveal choroidal thickness after intravitreal ranibizumab or...